Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

Published Date: 13 Jul 2025

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL

2.

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

3.

Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus

4.

Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.

5.

Treatment of Oligometastatic EGFR-Mutant Lung Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot